πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Theravance Biopharma Ireland Patents

Full USPTO pharma patent portfolio for Theravance Biopharma Ireland β€” grant dates, expiration, and drug cross-links.

Patents
635
Expiring ≀24m
58

Quick answer

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months β€” use filters for patent-cliff planning.

Page 5 of 14

  1. US 9290491

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9283183

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9273008

    Dual-acting imidazole antihypertensive agents

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9271965

    Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9260414

    Inhibitors of hepatitic C virus

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9249105

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9249099

    Crystalline forms of a biphenyl compound

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9226896

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9227933

    3-phenoxymethylpyrrolidine compounds

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9221763

    Process for preparing biphenyl imidazole compounds

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9216971

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9216970

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9212168

    Hepatitis C virus inhibitors

    Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9206159

    Piperazine-piperidine compounds as hepatitis C virus inhibitors

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9206172

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9199993

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9198899

    Dual-acting benzoimidazole antihypertensive agents

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9187423

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9181206

    Dual-acting oxazole antihypertensive agents

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9161990

    Hydrochloride salts of a glycopeptide-cephalosporin antbiotic compond

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9162982

    4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9150500

    Neprilysin inhibitors

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9150514

    Dual-acting antihypertensive agents

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9126956

    Neprilysin inhibitors

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9126994

    Crystalline form of a quinolinone-carboxamide compound

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9120758

    Neprilysin inhibitors

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9120747

    Neprilysin inhibitors

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9120746

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9108934

    Neprilysin inhibitors

    Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9096496

    Neprilysin inhibitors

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9073859

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9066944

    Hepatitis C virus inhibitors

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9045443

    Nitric oxide donor neprilysin inhibitors

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9035061

    Process for preparing a biphenyl-2-ylcarbamic acid

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9012460

    1-(2-phenoxymethylphenyl)piperazine compounds

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9012485

    Dual-acting imidazole antihypertensive agents

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9000191

    Serotonin reuptake inhibitors

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9000173

    Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonist activity

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8993752

    Neprilysin inhibitors

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8969367

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8969571

    Biphenyl derivatives

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8969403

    Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8969370

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8962653

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8952031

    Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8946233

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8933249

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8933111

    Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.